Lithium succinate

Lithium succinate
Clinical data
ATC code	D11AX04 (WHO) ;
Identifiers
	IUPAC name lithium butanedioic acid;
PubChem CID	65248;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C4H5LiO4
Molar mass	124.02 g/mol

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis^[1] and proposed for the treatment of anogenital warts.^[2]

References

↑ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel). 187 (2): 149–50. PMID 8358107.
↑ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS. 8 (8): 515–7. PMID 9259500.

Clinical data

ATC code	D11AX04 (WHO)
Identifiers
IUPAC name lithium butanedioic acid
PubChem CID	65248
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₄H₅LiO₄
Molar mass	124.02 g/mol